285 related articles for article (PubMed ID: 31200864)
1. Ligand-induced genetic degradation as a tool for target validation.
Yesbolatova A; Tominari Y; Kanemaki MT
Drug Discov Today Technol; 2019 Apr; 31():91-98. PubMed ID: 31200864
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule degron with a phenylpropionic acid scaffold.
Tomoshige S; Komatsu F; Kikuchi T; Sugiyama M; Kawasaki Y; Ohgane K; Furuyama Y; Sato S; Ishikawa M; Kuramochi K
Bioorg Med Chem; 2024 Jun; 109():117789. PubMed ID: 38870716
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins.
Yang Y; Wu Z; Chen P; Zheng P; Zhang H; Zhou J
Future Med Chem; 2020 Sep; 12(18):1669-1683. PubMed ID: 32893690
[TBL] [Abstract][Full Text] [Related]
4. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
Guenette RG; Potts PR
Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
[TBL] [Abstract][Full Text] [Related]
5. Ligand-induced degrons for studying nuclear functions.
Kanemaki MT
Curr Opin Cell Biol; 2022 Feb; 74():29-36. PubMed ID: 35065444
[TBL] [Abstract][Full Text] [Related]
6. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Gu S; Cui D; Chen X; Xiong X; Zhao Y
Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
[TBL] [Abstract][Full Text] [Related]
7. Targeted protein degradation and drug discovery.
Naito M
J Biochem; 2022 Jul; 172(2):61-69. PubMed ID: 35468190
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis-targeting chimeras for targeting protein for degradation.
Qi J; Zhang G
Future Med Chem; 2019 Apr; 11(7):723-741. PubMed ID: 30706727
[TBL] [Abstract][Full Text] [Related]
9. Targeting Cancer Cells via N-degron-based PROTACs.
Eldeeb MA; Zorca CE; Fahlman RP
Endocrinology; 2020 Dec; 161(12):. PubMed ID: 33159513
[TBL] [Abstract][Full Text] [Related]
10. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
[TBL] [Abstract][Full Text] [Related]
11. Targeted Protein Degradation Tools: Overview and Future Perspectives.
Prozzillo Y; Fattorini G; Santopietro MV; Suglia L; Ruggiero A; Ferreri D; Messina G
Biology (Basel); 2020 Nov; 9(12):. PubMed ID: 33256092
[TBL] [Abstract][Full Text] [Related]
12. Two-Stage Strategy for Development of Proteolysis Targeting Chimeras and its Application for Estrogen Receptor Degraders.
Roberts BL; Ma ZX; Gao A; Leisten ED; Yin D; Xu W; Tang W
ACS Chem Biol; 2020 Jun; 15(6):1487-1496. PubMed ID: 32255606
[TBL] [Abstract][Full Text] [Related]
13. Generation of conditional auxin-inducible degron (AID) cells and tight control of degron-fused proteins using the degradation inhibitor auxinole.
Yesbolatova A; Natsume T; Hayashi KI; Kanemaki MT
Methods; 2019 Jul; 164-165():73-80. PubMed ID: 31026591
[TBL] [Abstract][Full Text] [Related]
14. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads.
Dobrodziej J; Dong H; Zimmermann K; Hickey CM
Methods Mol Biol; 2021; 2365():59-75. PubMed ID: 34432239
[TBL] [Abstract][Full Text] [Related]
16. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
Riching KM; Caine EA; Urh M; Daniels DL
Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
[TBL] [Abstract][Full Text] [Related]
17. Targeted Protein Depletion Using the Auxin-Inducible Degron 2 (AID2) System.
Saito Y; Kanemaki MT
Curr Protoc; 2021 Aug; 1(8):e219. PubMed ID: 34370399
[TBL] [Abstract][Full Text] [Related]
18. Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development.
Cooper MS; Norley MC; Armitage S; Cresser-Brown JO; Edmonds AK; Goggins S; Hopewell JP; Karadogan B; Knights KA; Nash TJ; Oakes CS; O'Neill WJ; Pridmore SJ; Maple HJ; Marsh GP
Org Biomol Chem; 2023 Oct; 21(41):8344-8352. PubMed ID: 37800999
[TBL] [Abstract][Full Text] [Related]
19. Major Advances in Emerging Degrader Technologies.
Luo H; Wu L; He Y; Qin C; Tang X
Front Cell Dev Biol; 2022; 10():921958. PubMed ID: 35813205
[TBL] [Abstract][Full Text] [Related]
20. The Present and Future of Novel Protein Degradation Technology.
Xia L; Liu W; Song Y; Zhu H; Duan Y
Curr Top Med Chem; 2019; 19(20):1784-1788. PubMed ID: 31644408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
